Rick Doblin

6.3k total citations · 2 hit papers
36 papers, 2.8k citations indexed

About

Rick Doblin is a scholar working on Clinical Psychology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Rick Doblin has authored 36 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Clinical Psychology, 27 papers in Pharmacology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Rick Doblin's work include Psychedelics and Drug Studies (33 papers), Cannabis and Cannabinoid Research (25 papers) and Treatment of Major Depression (6 papers). Rick Doblin is often cited by papers focused on Psychedelics and Drug Studies (33 papers), Cannabis and Cannabinoid Research (25 papers) and Treatment of Major Depression (6 papers). Rick Doblin collaborates with scholars based in United States, Canada and United Kingdom. Rick Doblin's co-authors include Michael C. Mithoefer, Lisa Jerome, Berra Yazar‐Klosinski, Ann T. Mithoefer, Mark T. Wagner, Yvonne Michel, Amy Emerson, Dominique Holstein, Rudolf Brenneisen and Torsten Passie and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Rick Doblin

35 papers receiving 2.6k citations

Hit Papers

Safety and Efficacy of Lysergic Acid Diethylamide-Assiste... 2014 2026 2018 2022 2014 2018 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
    2014 493 citations Peter Gasser, Dominique Holstein et al. The Journal of Nervous and Mental Disease profile →
  2. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial
    2018 272 citations Michael C. Mithoefer, Ann T. Mithoefer et al. The Lancet Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rick Doblin United States 22 2.4k 1.1k 921 845 469 36 2.8k
Berra Yazar‐Klosinski United States 18 1.9k 0.8× 913 0.8× 808 0.9× 591 0.7× 319 0.7× 28 2.2k
Torsten Passie Germany 24 2.1k 0.9× 1.1k 1.0× 1.1k 1.2× 470 0.6× 297 0.6× 50 2.7k
Yasmin Schmid Switzerland 27 2.1k 0.9× 1.2k 1.1× 846 0.9× 446 0.5× 472 1.0× 57 2.7k
Michael C. Mithoefer United States 18 1.9k 0.8× 812 0.7× 607 0.7× 682 0.8× 397 0.8× 29 2.1k
Lisa Jerome United States 19 1.8k 0.7× 808 0.7× 583 0.6× 688 0.8× 463 1.0× 25 2.1k
John H. Halpern United States 23 1.3k 0.6× 814 0.7× 674 0.7× 453 0.5× 367 0.8× 38 2.3k
Charles S. Grob United States 33 3.1k 1.3× 1.6k 1.4× 1.1k 1.1× 1.0k 1.2× 733 1.6× 71 4.2k
Kim P. C. Kuypers Netherlands 39 2.9k 1.2× 1.7k 1.5× 1.3k 1.4× 1.1k 1.3× 855 1.8× 127 4.3k
Natasha L. Mason Netherlands 26 1.8k 0.8× 977 0.9× 1.0k 1.1× 343 0.4× 209 0.4× 73 2.2k
Valerie H. Curran United Kingdom 10 1.1k 0.5× 765 0.7× 600 0.7× 639 0.8× 179 0.4× 15 1.9k

Countries citing papers authored by Rick Doblin

Since Specialization
Citations

This map shows the geographic impact of Rick Doblin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rick Doblin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rick Doblin more than expected).

Fields of papers citing papers by Rick Doblin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rick Doblin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rick Doblin. The network helps show where Rick Doblin may publish in the future.

Co-authorship network of co-authors of Rick Doblin

This figure shows the co-authorship network connecting the top 25 collaborators of Rick Doblin. A scholar is included among the top collaborators of Rick Doblin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rick Doblin. Rick Doblin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Julie B., Rachel Yehuda, Allison R. Coker, et al.. (2024). Effects of MDMA-assisted therapy for PTSD on self-experience. PLoS ONE. 19(1). e0295926–e0295926. 14 indexed citations
2.
Singleton, S. Parker, Julie B. Wang, Michael C. Mithoefer, et al.. (2023). Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder. Frontiers in Psychiatry. 13. 947622–947622. 21 indexed citations
3.
Barnett, Brian S., Kathleen M Ziegler, Rick Doblin, & Andrew D. Carlo. (2022). Is psychedelic use associated with cancer?: Interrogating a half-century-old claim using contemporary population-level data. Journal of Psychopharmacology. 36(10). 1118–1128. 9 indexed citations
4.
Brewerton, Timothy D., Julie B. Wang, Adèle Lafrance, et al.. (2022). MDMA-assisted therapy significantly reduces eating disorder symptoms in a randomized placebo-controlled trial of adults with severe PTSD. Journal of Psychiatric Research. 149. 128–135. 40 indexed citations
5.
Wang, Julie B., Jessica Lin, Allison R. Coker, et al.. (2021). Scaling Up: Multisite Open-Label Clinical Trials of MDMA-Assisted Therapy for Severe Posttraumatic Stress Disorder. Journal of Humanistic Psychology. 14 indexed citations
6.
Pascoe, Michael, Fiona Chapman, Andrew D. Westwell, et al.. (2021). Online survey into developing a model for a legal cannabis market in the United Kingdom. ORCA Online Research @Cardiff (Cardiff University). 7. 1 indexed citations
7.
Roseman, Leor, et al.. (2021). Relational Processes in Ayahuasca Groups of Palestinians and Israelis. Frontiers in Pharmacology. 12. 607529–607529. 25 indexed citations
8.
Bonn‐Miller, Marcel O., Paula Riggs, Berra Yazar‐Klosinski, et al.. (2021). The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trial. PLoS ONE. 16(3). e0246990–e0246990. 58 indexed citations
9.
Feduccia, Allison A., Lisa Jerome, Julie B. Wang, et al.. (2020). MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study. Scientific Reports. 10(1). 20442–20442. 88 indexed citations
10.
Marseille, Elliot, James G. Kahn, Berra Yazar‐Klosinski, & Rick Doblin. (2020). The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD. PLoS ONE. 15(10). e0239997–e0239997. 32 indexed citations
11.
Barnett, Brian S., Yvan Beaussant, Franklin King, & Rick Doblin. (2020). Psychedelic knowledge and opinions in psychiatric professional conference attendees: Survey instrument. Figshare. 2 indexed citations
12.
Feduccia, Allison A., Lisa Jerome, Berra Yazar‐Klosinski, et al.. (2019). Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline. Frontiers in Psychiatry. 10. 650–650. 108 indexed citations
13.
Mithoefer, Michael C., Ann T. Mithoefer, Allison A. Feduccia, et al.. (2018). 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. The Lancet Psychiatry. 5(6). 486–497. 272 indexed citations breakdown →
14.
Loetz, Esteban C., et al.. (2018). 3,4-methylenedioxymethamphetamine (MDMA) impairs the extinction and reconsolidation of fear memory in rats. Physiology & Behavior. 199. 343–350. 43 indexed citations
15.
Gasser, Peter, Dominique Holstein, Yvonne Michel, et al.. (2014). Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases. The Journal of Nervous and Mental Disease. 202(7). 513–520. 493 indexed citations breakdown →
16.
Mithoefer, Michael C., Mark T. Wagner, Ann T. Mithoefer, Lisa Jerome, & Rick Doblin. (2010). The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. Journal of Psychopharmacology. 25(4). 439–452. 446 indexed citations
17.
Bouso, José Carlos, Rick Doblin, Magı́ Farré, Miguel Ángel Alcázar‐Córcoles, & Gregorio Gómez-Jarabo. (2008). MDMA-Assisted Psychotherapy Using Low Doses in a Small Sample of Women with Chronic Posttraumatic Stress Disorder. Journal of Psychoactive Drugs. 40(3). 225–236. 130 indexed citations
18.
Grinspoon, Lester & Rick Doblin. (2001). Psychedelics as catalysts of insight-oriented psychotherapy. Social research. 68(3). 677–695. 19 indexed citations
19.
Doblin, Rick. (1998). Dr. Leary's Concord Prison Experiment: A 34-Year Follow-up Study. Journal of Psychoactive Drugs. 30(4). 419–426. 22 indexed citations
20.
Doblin, Rick, et al.. (1991). Marijuana as antiemetic medicine: a survey of oncologists' experiences and attitudes.. Journal of Clinical Oncology. 9(7). 1314–1319. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Berra Yazar‐Klosinski Breakdown of academic impact, for papers by Torsten Passie Breakdown of academic impact, for papers by Yasmin Schmid Breakdown of academic impact, for papers by Michael C. Mithoefer Breakdown of academic impact, for papers by Lisa Jerome Breakdown of academic impact, for papers by John H. Halpern Breakdown of academic impact, for papers by Charles S. Grob Breakdown of academic impact, for papers by Kim P. C. Kuypers Breakdown of academic impact, for papers by Natasha L. Mason Breakdown of academic impact, for papers by Valerie H. Curran
Rankless by CCL
2026